Works by Kleha, Joseph F.

Results: 2
    1

    POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae033
    By:
    • Menzies, Alexander M;
    • Long, Georgina V;
    • Kohn, Amiee;
    • Tawbi, Hussein;
    • Weber, Jeffrey;
    • Flaherty, Keith;
    • McArthur, Grant A;
    • Ascierto, Paolo A;
    • Pfluger, Yanina;
    • Lewis, Karl;
    • Tsai, Katy K;
    • Hamid, Omid;
    • Prenen, Hans;
    • Fein, Luis;
    • Wang, Erjian;
    • Guenzel, Carolin;
    • Zhang, Fan;
    • Kleha, Joseph F;
    • Pietro, Alessandra di;
    • Davies, Michael A
    Publication type:
    Article
    2

    Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.

    Published in:
    2020
    By:
    • Tolcher, Anthony W.;
    • Kurzrock, Razelle;
    • Valero, Vincente;
    • Gonzalez, Rene;
    • Heist, Rebecca S.;
    • Tan, Antoinette R.;
    • Means-Powell, Julie;
    • Werner, Theresa L.;
    • Becerra, Carlos;
    • Wang, Chenxi;
    • Leonowens, Cathrine;
    • Kalyana-Sundaram, Shanker;
    • Kleha, Joseph F.;
    • Gauvin, Jennifer;
    • D'Amelio, Anthony M.;
    • Ellis, Catherine;
    • Ibrahim, Nageatte;
    • Yan, Li;
    • D'Amelio, Anthony M Jr
    Publication type:
    journal article